Skip to content
‹ Back to IndustriesHealthcare

Catching Up With George Stringer of Soraa at LFI 2018

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer. “The nice thing about LightFair this year is that we were selected as one of the top ten booths to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer.

“The nice thing about LightFair this year is that we were selected as one of the top ten booths to see because of an award-winning product,” Stringer said. “People forget that we’re a technology company first. We’re a semiconductor company. We make violet based semiconductors in Freemont, California, because we believe that natural light should mirror what the sunlight does.”

For Soraa, there is an understanding that to meet their customers’ needs, the technology must be perfected before applications and products are even discussed. It is this dedication to the small details that has made them so popular with companies who crave the aesthetic provided by natural light.

“The people who care most about color quality would be museums, retail, high end, residential and hospitality. Those are the markets that we cater to,” Stringer said. “We’ve started focusing primarily on retail because that’s where light and color really matter.”

Stringer stopped to show us one of their cutting-edge designs, the Radiant GU10. It is a directional light that allows for proper lighting in spaces where display is essential.

“Museums are a critical vertical for us. If you think about what they’re trying to do in terms of color for the artwork and sculptures – if you’re going to have beautiful antiquities and art you want to light them with the best color quality of light,” he said. “I would say we’ve done close to 300 museums in North America alone,” Stringer noted.

Internationally, the company has a strong presence as well. Soraa’s products even light up the Palace of Versailles. Stringer believes much of this success is simply because they listen to what customers are asking for and find ways to make that a reality. When more lumens were required, they found a way to develop fixtures with more design freedom to incorporate heat sinks. And when it was discovered that violet light can be used to get rid of unwanted bacteria, the company began to develop innovative concepts using the technology they already had at their disposal.

“We found that we can increase the output of violet light to 405 nanometers and kill most of the bacteria in an eight-hour period,” Stringer said. “Violet has many purposes, it renders white, it gives better color, it gives a healthy light solution and it has medical applications for bacteria removal. We’re doing all of that for technology today, but also for products for the future.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512